Aureum Diagnostics Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$1.54M
- Investors
-
3
Aureum Diagnostics General Information
Description
Developer of a diagnosis and testing tool designed to diagnose COVID and other life-threatening conditions. The company's electrochemical sensor and handheld low-cost instrument platform combine proprietary sensors, reagents, and instrumentation innovations, enabling clinicians to get a rapid and extremely sensitive measurement of multiple biologically important targets.
Contact Information
Website
aureumdx.co.ukCorporate Office
- Second Floor, Suite 1
- Maxim 1, 2 Parklands Way Maxim Park Eurocentral
- Glasgow ML1 4WR
- Scotland, United Kingdom
Corporate Office
- Second Floor, Suite 1
- Maxim 1, 2 Parklands Way Maxim Park Eurocentral
- Glasgow ML1 4WR
- Scotland, United Kingdom
Aureum Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 12-May-2022 | $1.54M | Completed | Generating Revenue | ||
| 1. University Spin-Out | 15-Feb-2021 | Completed | Startup |
Aureum Diagnostics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| A Ordinary | ||||||||
| Ordinary A1 | ||||||||
| Ordinary A1 | 289,280 | $0.012688 | $3.39 | $3.39 | 1x | $3.39 | 5.44% |
Aureum Diagnostics Patents
Aureum Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202415468-D0 | Methods and fuel cell devices for detecting analytes | Pending | 21-Oct-2024 | ||
| WO-2026087880-A1 | Methods and fuel cell devices for detecting analytes | Pending | 21-Oct-2024 | ||
| GB-202415467-D0 | Test strip | Pending | 21-Oct-2024 | ||
| WO-2026087882-A1 | Test strip | Pending | 21-Oct-2024 | ||
| EP-4795191-A1 | Methods and systems for electrochemical detection | Pending | 19-Oct-2023 | C12Q1/005 |
Aureum Diagnostics Signals
Aureum Diagnostics Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Innova Partnerships | Venture Capital | Minority | ||
| Norcliffe Capital | Venture Capital | Minority | ||
| The University of Strathclyde | University | Minority |
Aureum Diagnostics FAQs
-
When was Aureum Diagnostics founded?
Aureum Diagnostics was founded in 2021.
-
Where is Aureum Diagnostics headquartered?
Aureum Diagnostics is headquartered in Glasgow, United Kingdom.
-
What is the size of Aureum Diagnostics?
Aureum Diagnostics has 11 total employees.
-
What industry is Aureum Diagnostics in?
Aureum Diagnostics’s primary industry is Diagnostic Equipment.
-
Is Aureum Diagnostics a private or public company?
Aureum Diagnostics is a Private company.
-
What is the current valuation of Aureum Diagnostics?
The current valuation of Aureum Diagnostics is .
-
What is Aureum Diagnostics’s current revenue?
The current revenue for Aureum Diagnostics is .
-
How much funding has Aureum Diagnostics raised over time?
Aureum Diagnostics has raised $1.54M.
-
Who are Aureum Diagnostics’s investors?
Innova Partnerships, Norcliffe Capital, and The University of Strathclyde have invested in Aureum Diagnostics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process